Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia - PubMed (original) (raw)
. 1996 Jan 18;12(2):323-36.
Affiliations
- PMID: 8570209
Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia
J D Licht et al. Oncogene. 1996.
Abstract
Acute promyelocytic leukemia (APL) associated with chromosomal rearrangement t(11;17) is a distinct syndrome which, unlike typical t(15;17) APL, fails to respond to all-trans retinoic acid (ATRA) therapy. In t(11;17) the PLZF gene, encoding a Krüppel-like zinc finger protein, is fused to the retinoic acid receptor-alpha (RAR alpha) gene, yielding two classes of chimeric proteins. PLZF protein was found in the nucleus in a punctate speckled pattern that differed from the nuclear body expression pattern of the PML protein affected in t(15;17) APL. The reciprocal PLZF-RAR alpha and RAR alpha-PLZF fusion proteins were localized to the nucleus both in the presence and absence of ATRA. PLZF-RAR alpha, in combination with the retinoid X receptor (RXR) bound to a retinoic acid-responsive element (RARE) less efficiently than RAR alpha and formed multimeric DNA-protein complexes. PLZF-RAR alpha stimulated ATRA-dependent transcription of RARE-containing reporter genes with diminished activity compared to wild-type RAR alpha. In addition, PLZF-RAR alpha antagonized the function of coexpressed wild-type RAR alpha, an effect relieved by over-expression of RXR. Leukemogenesis in t(11;17) APL may be related to interference with ATRA-mediated differentiation due to sequestration of RXR by the PLZF-RAR alpha chimera. However, disruption of the function of the myeloid-specific PLZF protein may also play an important role.
Similar articles
- Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
Chen SJ, Zelent A, Tong JH, Yu HQ, Wang ZY, Derré J, Berger R, Waxman S, Chen Z. Chen SJ, et al. J Clin Invest. 1993 May;91(5):2260-7. doi: 10.1172/JCI116453. J Clin Invest. 1993. PMID: 8387545 Free PMC article. - Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation.
Nervi C, Poindexter EC, Grignani F, Pandolfi PP, Lo Coco F, Avvisati G, Pelicci PG, Jetten AM. Nervi C, et al. Cancer Res. 1992 Jul 1;52(13):3687-92. Cancer Res. 1992. PMID: 1319828 - Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
Chen Z, Chen SJ, Wang ZY. Chen Z, et al. C R Acad Sci III. 1994 Dec;317(12):1135-41. C R Acad Sci III. 1994. PMID: 7697468 Review. - The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain.
Sitterlin D, Tiollais P, Transy C. Sitterlin D, et al. Oncogene. 1997 Mar 6;14(9):1067-74. doi: 10.1038/sj.onc.1200916. Oncogene. 1997. PMID: 9070655 - Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ, Wang ZY, Chen Z. Chen SJ, et al. Stem Cells. 1995 Jan;13(1):22-31. doi: 10.1002/stem.5530130104. Stem Cells. 1995. PMID: 7719245 Review.
Cited by
- Promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF-RARα), an oncogenic transcriptional repressor of cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) and tumor protein p53 (TP53) genes.
Choi WI, Yoon JH, Kim MY, Koh DI, Licht JD, Kim K, Hur MW. Choi WI, et al. J Biol Chem. 2014 Jul 4;289(27):18641-56. doi: 10.1074/jbc.M113.538777. Epub 2014 May 12. J Biol Chem. 2014. PMID: 24821728 Free PMC article. - Immunohistochemical detection of promyelocytic leukemia zinc finger and histone 1.5 in uterine leiomyosarcoma and leiomyoma.
Momeni M, Kalir T, Farag S, Kinoshita Y, Roman TY, Chuang L, Fishman DA, Burstein DE. Momeni M, et al. Reprod Sci. 2014 Sep;21(9):1171-6. doi: 10.1177/1933719114532845. Epub 2014 Apr 30. Reprod Sci. 2014. PMID: 24784718 Free PMC article. - Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.
Rice KL, Hormaeche I, Doulatov S, Flatow JM, Grimwade D, Mills KI, Leiva M, Ablain J, Ambardekar C, McConnell MJ, Dick JE, Licht JD. Rice KL, et al. Blood. 2009 Dec 24;114(27):5499-511. doi: 10.1182/blood-2009-03-206524. Epub 2009 Oct 23. Blood. 2009. PMID: 19855079 Free PMC article. - Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB, Zhang J, Wang ZY, Chen SJ, Chen Z. Zhou GB, et al. Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):959-71. doi: 10.1098/rstb.2007.2026. Philos Trans R Soc Lond B Biol Sci. 2007. PMID: 17317642 Free PMC article. Review. - Distinct roles of Broad isoforms in regulation of the 20-hydroxyecdysone effector gene, Vitellogenin, in the mosquito Aedes aegypti.
Zhu J, Chen L, Raikhel AS. Zhu J, et al. Mol Cell Endocrinol. 2007 Mar 15;267(1-2):97-105. doi: 10.1016/j.mce.2007.01.006. Epub 2007 Jan 20. Mol Cell Endocrinol. 2007. PMID: 17303321 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources